Milestone Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	73.05	25.31	13.76	7.64	114.14
Short-Term Investments	32.91	44.38	52.24	56.95	-
Cash & Short-Term Investments	105.96	69.7	66	64.59	114.14
Cash Growth	52.03%	5.59%	2.20%	-43.42%	-19.79%
Other Receivables	3.51	1.72	1.45	1.21	0.48
Receivables	3.51	1.72	1.45	1.21	0.48
Inventory	0.65	-	-	-	-
Prepaid Expenses	1.81	1.84	3.18	6.01	4.3
Other Current Assets	-	0.67	2.4	-	-
Total Current Assets	111.92	73.93	73.03	71.8	118.92
Property, Plant & Equipment	1.64	1.57	2.19	2.68	0.93
Total Assets	113.56	75.5	75.23	74.48	119.85
Accounts Payable	13.29	1.93	3.98	2.26	4.38
Accrued Expenses	-	5.62	2.7	3.38	2.17
Current Portion of Leases	0.65	0.57	0.55	0.5	0.22
Other Current Liabilities	0.04	-	-	-	-
Total Current Liabilities	13.98	8.13	7.23	6.14	6.78
Long-Term Debt	57.19	53.35	49.77	-	-
Long-Term Leases	0.54	0.87	1.46	2	0.47
Other Long-Term Liabilities	0.08	-	-	-	-
Total Liabilities	71.79	62.35	58.46	8.14	7.25
Common Stock	352.62	288.05	260.5	273.9	251.9
Additional Paid-In Capital	64.1	39.57	33.83	24.44	15.71
Retained Earnings	-430.6	-367.55	-326.03	-266.34	-207.95
Comprehensive Income & Other	55.65	53.08	48.46	34.35	52.94
Total Common Equity	41.77	13.15	16.77	66.35	112.6
Shareholders' Equity	41.77	13.15	16.77	66.35	112.6
Total Liabilities & Equity	113.56	75.5	75.23	74.48	119.85
Total Debt	58.38	54.8	51.78	2.49	0.7
Net Cash (Debt)	47.58	14.9	14.23	62.09	113.44
Net Cash Growth	219.39%	4.71%	-77.09%	-45.26%	-19.75%
Net Cash Per Share	0.57	0.24	0.33	1.46	2.71
Filing Date Shares Outstanding	117.67	66.26	43.06	42.8	42.23
Total Common Shares Outstanding	122.65	66.26	43.06	42.8	42.23
Working Capital	97.94	65.8	65.81	65.66	112.15
Book Value Per Share	0.34	0.20	0.39	1.55	2.67
Tangible Book Value	41.77	13.15	16.77	66.35	112.6
Tangible Book Value Per Share	0.34	0.20	0.39	1.55	2.67
Machinery	-	0.4	0.38	0.28	0.43
Leasehold Improvements	-	0.09	0.09	0.1	0.03

Updated Mar 20, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q